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What is already known {#bph14762-sec-0006}
=====================

TRPV4 channels are key Ca^2+^ permeable channels that control endothelial function.TRPV4 channels generate large but highly localized Ca^2+^ signals.

What this study adds {#bph14762-sec-0007}
====================

Ca^2+^‐induced Ca^2+^ release from IP~3~‐sensitive internal store amplifies local Ca^2+^ signals from TRPV4 channel activity.Ca^2+^‐induced Ca^2+^ release at IP~3~ receptors mediates control of vascular contractility by endothelial TRPV4 channels.

What is the clinical significance {#bph14762-sec-0008}
=================================

Endothelial TRPV4 channels are involved in several disease conditions such as cancer progression and hypertension.Endothelial TRPV4‐mediated Ca^2+^‐induced Ca^2+^ release at IP~3~ receptors offers a new target for drug development.

1. INTRODUCTION {#bph14762-sec-0009}
===============

The endothelium plays a critical role in the regulation of numerous vascular processes such as maintaining vascular tone, regulating the passage of macromolecules and oxygen to tissues, modulating immune responses, initiating angiogenesis, and controlling vascular remodelling. The control by the endothelium of each process is mediated by the generation of various signalling molecules that include NO, prostacyclin, von Willebrand factor, tissue plasminogen activator, and endothelial‐derived hyperpolarizing and contracting factors (Taylor et al., [2003](#bph14762-bib-0076){ref-type="ref"}; Whorton, Willis, Kent, & Young, [1984](#bph14762-bib-0086){ref-type="ref"}). The generation of each of these signalling molecules is controlled tightly by changes in the cytoplasmic Ca^2+^ concentration in the endothelium. Central therefore to an understanding of endothelial function is an appreciation of the control of intracellular Ca^2+^ concentrations.

There are two major sources of Ca^2+^ for the endothelium: the extracellular space and the intracellular Ca^2+^ store. Ca^2+^ influx from the extracellular space is mediated mainly by channels present on the plasmalemmal membrane. In many cell types, such as smooth muscle and cardiomyocytes, the influx pathways are well characterized, and [voltage‐dependent Ca^2+^ channels](http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=80) are major contributors (Catterall, [2011](#bph14762-bib-0012){ref-type="ref"}; Nelson, Patlak, Worley, & Standen, [1990](#bph14762-bib-0053){ref-type="ref"}). In endothelial cells, however, understanding of the Ca^2+^ influx pathways is incomplete (Nilius, Droogmans, & Wondergem, [2003](#bph14762-bib-0054){ref-type="ref"}). Several members of the transient receptor potential (TRP) superfamily of cation channels are present in endothelial cells (Hofmann, Schaefer, Schultz, & Gudermann, [2002](#bph14762-bib-0029){ref-type="ref"}; Nilius, Droogmans, & Wondergem, [2003](#bph14762-bib-0054){ref-type="ref"}). Of these, the [TRPV4](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=510) channel has attracted substantial interest because of the channels\' relatively high Ca^2+^ permeability (Filosa, Yao, & Rath, [2013](#bph14762-bib-0018){ref-type="ref"}; Watanabe et al., [2002](#bph14762-bib-0083){ref-type="ref"}). TRPV4 channels are expressed widely in endothelial cells (Mendoza et al., [2010](#bph14762-bib-0048){ref-type="ref"}; Sullivan, Francis, Pitts, Taylor, & Earley, [2012](#bph14762-bib-0073){ref-type="ref"}; Watanabe et al., [2002](#bph14762-bib-0083){ref-type="ref"}). TRPV4 channels were initially demonstrated to be activated by hypotonicity‐induced cell swelling (Liedtke et al., [2000](#bph14762-bib-0036){ref-type="ref"}; Mizuno, Matsumoto, Imai, & Suzuki, [2003](#bph14762-bib-0049){ref-type="ref"}). Later studies revealed that the channel is also activated by various other stimuli including mechanical stimulation (Gao, Wu, & O\'Neil, [2003](#bph14762-bib-0023){ref-type="ref"}; Kohler et al., [2006](#bph14762-bib-0031){ref-type="ref"}; Liedtke, Tobin, Bargmann, & Friedman, [2003](#bph14762-bib-0037){ref-type="ref"}), moderate heat, endogenous chemicals such as [anandamide](http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2364), [arachidonic acid](http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2391), and its epoxyeicosatrienoic acid metabolites, as well as by a number of exogenous chemical ligands (Nilius & Voets, [2013](#bph14762-bib-0055){ref-type="ref"}; Vriens et al., [2004](#bph14762-bib-0082){ref-type="ref"}; Watanabe et al., [2003](#bph14762-bib-0085){ref-type="ref"}) or UVB (Moore et al., [2013](#bph14762-bib-0051){ref-type="ref"}; Yin et al., [2008](#bph14762-bib-0092){ref-type="ref"}). In the endothelium, by regulating the cytoplasmic Ca^2+^ concentration, TRPV4 channels may contribute to the response to arachidonic acid metabolites, physical forces, and agonists (Bagher et al., [2012](#bph14762-bib-0007){ref-type="ref"}; Freichel et al., [2001](#bph14762-bib-0021){ref-type="ref"}; Hartmannsgruber et al., [2007](#bph14762-bib-0028){ref-type="ref"}; Kohler et al., [2006](#bph14762-bib-0031){ref-type="ref"}; Marrelli, O\'Neil, Brown, & Bryan, [2007](#bph14762-bib-0042){ref-type="ref"}; Mendoza et al., [2010](#bph14762-bib-0048){ref-type="ref"}; Watanabe et al., [2002](#bph14762-bib-0083){ref-type="ref"}; Zhang et al., [2009](#bph14762-bib-0093){ref-type="ref"};Zhang, Papadopoulos, & Hamel, [2013](#bph14762-bib-0094){ref-type="ref"}).

While large in amplitude, the Ca^2+^ rise evoked by activation of endothelial TRPV4 channels is reported to be highly localized and confined to within a few micrometres of the channels (Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}; Sonkusare et al., [2014](#bph14762-bib-0071){ref-type="ref"}). These highly localized Ca^2+^ signals evoke endothelial and smooth muscle hyperpolarization and vascular relaxation (F. Gao & Wang, [2010](#bph14762-bib-0022){ref-type="ref"}; Kohler et al., [2006](#bph14762-bib-0031){ref-type="ref"}; Ma et al., [2013](#bph14762-bib-0038){ref-type="ref"}; Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}; D. X. Zhang et al., [2009](#bph14762-bib-0093){ref-type="ref"}). The highly localized nature of the Ca^2+^ signal provides tight spatial control of the cellular effectors activated, for example, [Ca^2+^‐activated K^+^ channels](http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=69) (Gao & Wang, [2010](#bph14762-bib-0022){ref-type="ref"}; Ma et al., [2013](#bph14762-bib-0038){ref-type="ref"}; Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}). However, more widespread Ca^2+^ rises throughout the cytoplasm have been implicated in the regulation of endothelial structure, maintenance of the normal orientation of endothelial cells, the control and selectively of endothelial permeability, and the production of antithrombotic factors. TRPV4 channels have been proposed to play a role in each of these processes (Noren et al., [2016](#bph14762-bib-0057){ref-type="ref"}; Phuong et al., [2017](#bph14762-bib-0063){ref-type="ref"}; Thodeti et al., [2009](#bph14762-bib-0077){ref-type="ref"}; Thoppil et al., [2016](#bph14762-bib-0078){ref-type="ref"}). The question arises as to how activation of TRPV4 channels may lead to Ca^2+^‐dependent events throughout the cytoplasm if the increase in Ca^2+^ concentration arising from TRPV4 channel activity remains localized to within a few microns of the channel.

The second major source of Ca^2+^ in endothelial cells is the internal Ca^2+^ store. Ca^2+^ release from the internal store may occur via [ryanodine](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4303) receptors ([RyRs](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=125)) or [IP](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4222) ~3~ receptors ([IP](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=123) ~3~Rs). While RyRs may be expressed in endothelial cells (Moccia, Berra‐Romani, & Tanzi, [2012](#bph14762-bib-0050){ref-type="ref"}; Mumtaz, Burdyga, Borisova, Wray, & Burdyga, [2011](#bph14762-bib-0052){ref-type="ref"}; Rusko, Wang, & Vanbreemen, [1995](#bph14762-bib-0065){ref-type="ref"}), the functional role of the channels in the endothelium is not clear given that RyR activators such as [caffeine](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=407) do not increase cytoplasmic Ca^2+^ in endothelial cells (Borisova, Wray, Eisner, & Burdyga, [2009](#bph14762-bib-0011){ref-type="ref"}; Wilson et al., [2019](#bph14762-bib-0089){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}). Ca^2+^ release from the internal store in endothelial cells may be mediated mainly by IP~3~Rs (Mumtaz et al., [2011](#bph14762-bib-0052){ref-type="ref"}; Wilson et al., [2019](#bph14762-bib-0089){ref-type="ref"}). Ca^2+^ release via IP~3~R occurs in response to physical forces and circulating vasoactive substances and contributes to the control of several vascular activities such as vasorelaxation, endothelial permeability, and production of anti‐thrombotic factors (Sun, Geyer, & Komarova, [2017](#bph14762-bib-0074){ref-type="ref"}).

IP~3~Rs are themselves regulated by Ca^2+^, in addition to IP~3~. Ca^2+^ released via IP~3~Rs may induce a positive feedback Ca^2+^‐induced Ca^2+^ release process at neighbouring IP~3~Rs. Indeed, Ca^2+^ signals at IP~3~Rs begin as a localized Ca^2+^ blip at a single receptor (∼1 μm spread) which expand by Ca^2+^‐induced Ca^2+^ release opening neighbouring IP~3~Rs generating a Ca^2+^ puff (∼4 μm spread). Puffs may further propagate via Ca^2+^‐induced Ca^2+^ release to form a transient global Ca^2+^ elevation throughout the cell or a Ca^2+^ "wave" (Berridge, [1997](#bph14762-bib-0008){ref-type="ref"}; Bootman, Niggli, Berridge, & Lipp, [1997](#bph14762-bib-0009){ref-type="ref"}). These waves may move through all or part of the cell (Bootman, Berridge, & Lipp, [1997](#bph14762-bib-0010){ref-type="ref"}). In some conditions that are not fully understood, IP~3~‐evoked Ca^2+^ waves may also move between cells to provide a signalling system capable of coordinating the activity of many cells (Leybaert & Sanderson, [2012](#bph14762-bib-0035){ref-type="ref"}).

While Ca^2+^ influx and release are activated separately, they are not independent: Ca^2+^ influx can trigger release, and release can trigger influx (McCarron, Chalmers, Bradley, Macmillan, & Muir, [2006](#bph14762-bib-0043){ref-type="ref"}). In cardiomyocytes, Ca^2+^ influx via voltage‐dependent Ca^2+^ channels may activate RyRs to evoke a large rise in Ca^2+^, inducing cell contraction. In smooth muscle cells, TRPV4 channel activity may lead to Ca^2+^‐induced Ca^2+^ release acting at RyRs (Earley, Heppner, Nelson, & Brayden, [2005](#bph14762-bib-0015){ref-type="ref"}). In astrocytes, Ca^2+^‐induced Ca^2+^ release occurs in response to Ca^2+^ influx via TRPV4 channels but at IP~3~Rs rather than at RyRs. This process amplifies and propagates the Ca^2+^ signal arising from TRPV4‐mediated Ca^2+^ influx (Dunn, Hill‐Eubanks, Liedtke, & Nelson, [2013](#bph14762-bib-0014){ref-type="ref"}). TRPV4‐mediated Ca^2+^ influx may also lead to recruitment of IP~3~Rs and Ca^2+^‐induced Ca^2+^ release in murine‐derived cultured neuronal cells (Shen et al., [2018](#bph14762-bib-0069){ref-type="ref"}). These observations raise the possibility of TRPV4‐mediated Ca^2+^ influx being able to generate a more global increase in intracellular Ca^2+^ via Ca^2+^‐induced Ca^2+^ release in endothelial cells.

To explore this possibility, we examined the role that the internal store plays in regulating alterations in intracellular Ca^2+^ evoked by activation of TRPV4 channels. Here, we report that the IP~3~‐sensitive Ca^2+^ store is critical for the TRPV4‐evoked global Ca^2+^ rise in endothelial cells in intact blood vessels. Ca^2+^ influx generates Ca^2+^‐induced Ca^2+^ release at IP~3~Rs to evoke Ca^2+^ waves in the vascular endothelium. IP~3~R‐dependent Ca^2+^ waves are required for the endothelium‐dependent vascular smooth muscle cell relaxation in response to activation of TRPV4 channels.

2. METHODS {#bph14762-sec-0010}
==========

2.1. Animals {#bph14762-sec-0011}
------------

All animal care and experimental procedures complied with the relevant UK Home Office Regulations, (Schedule 1 of the Animals \[Scientific Procedures\] Act 1986, UK) and were approved by the University of Strathclyde Animal Welfare and Ethical Review Body. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., [2010](#bph14762-bib-0032){ref-type="ref"}) and with the recommendations made by the *British Journal of Pharmacology*. The Strathclyde Biological Protection Unit is a conventional unit which undertakes FELASA quarterly health monitoring. Male Sprague--Dawley rats (10--12 week old; 250--300 g), from an in‐house colony, were used for the study. Sprague--Dawley rats are a widely used experimental model with a wealth of background information to aid interpretation of results. The animals were housed three per cage, and the cage type was North Kent Plastic model RC2F with nesting material "Sizzle Nest." A 12:12 light dark cycle was used with a temperature range of 19--23°C (set point 21°C) and humidity levels between 45% and 65%. Animals had free access to fresh water and SDS diet RM1 (rodent maintenance). The enrichment in the cages was aspen wood chew sticks and hanging huts.

All experiments used first‐ or second‐order mesenteric arteries isolated from rats killed by either CO~2~ or by injection with pentobarbital; no differences in the results were observed with either method. Controls and experimental treatments were carried out in the same tissue, so blinding and randomization were not used.

2.2. High‐resolution imaging of endothelial Ca^2+^ signalling {#bph14762-sec-0012}
-------------------------------------------------------------

Arteries (diameter of 200--230 μm) were isolated from the mesenteric bed, cleaned, then cut and pinned flat *en face* (endothelial side facing up) on a Sylgard block. The endothelium was then preferentially loaded with Cal‐520/AM (5 μM; with 0.02% Pluronic F‐127) in physiological saline solution (PSS) at 37°C for 30 min (Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}; Wilson, Saunter, Girkin, & McCarron, [2016](#bph14762-bib-0091){ref-type="ref"}). Following incubation, arteries were gently washed with PSS, and the Sylgard blocks were placed face down on a custom flow chamber. Arteries were then continuously perfused with PSS at 1.5 ml·min^−1^ using a syringe pump. Endothelial Ca^2+^ activity was stimulated by swapping the PSS syringe for one containing [ACh](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=294) (100 nM) or [GSK1016790A](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4205) (GSK, 20 nM). GSK1016790A is a selective TRPV4 channel agonist and evokes Ca^2+^ influx in wild type but not TRPV4 channel knockout mice (Mannaa et al., [2018](#bph14762-bib-0040){ref-type="ref"}; Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}).

In experiments examining the effects of various pharmacological agents on stimulated endothelial Ca^2+^ signalling, drugs were added to the perfusate and remained thereafter. Images were acquired at 10 Hz using an inverted fluorescence microscope (Eclipse TE300, Nikon, Tokyo, Japan) equipped with a 40× objective (S Fluor, Nikon, Tokyo, Japan, NA = 1.3) and an electron‐multiplying charge‐coupled device camera (iXon Life; Andor Technology Limited, Belfast, Northern Ireland, UK) or on an upright epi‐fluorescence microscope (FN‐1, Nikon, Tokyo, Japan) equipped with a 60× objective (CFI Fluor, Nikon, Tokyo, Japan, NA = 1.0). Cal520/AM was excited at 488 nm using a monochrometer (Polychome IV, TILL Photonics, Graefelfing, Germany) or an LED illumination system (PE‐300Ultra, CoolLED, Andover, UK).

In some experiments, the endothelium was loaded with Cal‐520 (5 μM) and a membrane permeant, caged IP~3~ (5 μM), and the Ca^2+^ response to local photolysis of caged IP~3~ examined. In these experiments, the endothelium was imaged as above, and a xenon flash lamp (Rapp Optoelecktronic, Germany) was used to uncage IP~3~ (Olson, Chalmers, & McCarron, [2012](#bph14762-bib-0059){ref-type="ref"}; Olson, Sandison, Chalmers, & McCarron, [2012](#bph14762-bib-0060){ref-type="ref"}; Wilson et al., [2019](#bph14762-bib-0089){ref-type="ref"}).

2.3. Extraction and analysis of endothelial Ca^2+^ signals {#bph14762-sec-0013}
----------------------------------------------------------

Endothelial Ca^2+^ signals were extracted automatically from fluorescence recordings using custom written Python software (RRID:SCR_001658; Lee et al., [2018](#bph14762-bib-0034){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}; Wilson, Saunter, et al., [2016](#bph14762-bib-0091){ref-type="ref"}). In brief, cellular regions of interest (ROIs) were first generated from average‐intensity projections of each time series recording. Intensity projections were sharpened (un‐sharp mask filter) and thresholded, generating ROIs that encompassed the majority of each cell\'s area. To facilitate comparisons in paired experiments, for example, where Ca^2+^ activity was recorded before and after pharmacological inhibition, ROIs were aligned and tracked across separate image acquisitions. Only cells that remained within the field of view for all recordings were included.

Cellular Ca^2+^ signals were extracted by averaging fluorescence intensity within each of the ROIs, for each frame of the image stack. Raw fluorescence signals (F) were expressed as fractional changes in fluorescence intensity (F/F~0~) by dividing each intensity value by the average intensity of a 100‐frame period exhibiting the least activity/noise (F~0~, red in Figure [S1B](#bph14762-supitem-0002){ref-type="supplementary-material"}). The F~0~ period was determined automatically by calculating, in series, the derivative of the signal, the rolling (100‐frame) SD of the derivative, and the rolling (100‐frame) summation of the rolling SD. The minimum value of the rolling summation indicates the centre of the portion of the signal with the least activity/noise.

The Ca^2+^ response to activation of TRPV4 channels contained two main components: a "slow" persistent Ca^2+^ elevation rise in the baseline Ca^2+^ levels and fast intracellular Ca^2+^ waves. To determine the underlying mechanisms, we isolated the two components from each F/F~0~ trace. The slow persistent Ca^2+^ elevation (baseline) component of each signal was extracted by applying an asymmetric least squares (ALS) smoothing function (Figure [S1C--E](#bph14762-supitem-0002){ref-type="supplementary-material"}; Eilers & Boelens, [2005](#bph14762-bib-0017){ref-type="ref"}). Signalling metrics describing this slow persistent Ca^2+^ elevation (amplitude; time of activation, 10--90% rise time) were then calculated from a fitted sigmoidal curve (Figure [S1C--E](#bph14762-supitem-0002){ref-type="supplementary-material"}). Cells were considered to exhibit a persistent Ca^2+^ elevation if the slow F/F~0~ component rose by more than 10‐fold the SD of the baseline noise. The propagating Ca^2+^ wave (fast) component of each signal was extracted by dividing each F/F~0~ trace by the ALS‐smoothed signal. This procedure effectively flattens the baseline and removes any slow drift from the signal (Figure [S1C--E](#bph14762-supitem-0002){ref-type="supplementary-material"}). Peaks in each Ca^2+^ signal arising from the waves were then detected automatically, using a zero‐crossing detector on derivative F/F~0~ traces (Lee et al., [2018](#bph14762-bib-0034){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}). Various signal metrics (number of peaks, peak amplitudes, peak durations, 10--90% rise time, and 90--10% fall time) were extracted from the corresponding ALS‐smoothed F/F~0~ trace. Cells were considered to exhibit Ca^2+^ wave activity if the F/F~0~ component exhibited at least one event with an amplitude more than 10‐fold the SD of the baseline noise.

In some experiments, Ca^2+^ signals were calibrated using $\left\lbrack \mathit{Ca}^{2 +} \right\rbrack = K_{D}\frac{F - F_{\min}}{F_{\max} - F}$, where *K* ~D~ = 320 nM. *F* ~max~ was determined at the end of the experiment by the addition of ionomycin (1 μM) and *F* ~min~ the signal in the absence of light to the camera.

2.4. Measurement of vascular reactivity {#bph14762-sec-0014}
---------------------------------------

To assess the endothelium dependence of contractile and dilation responses, vascular reactivity to various agonists were assessed in *en face* artery preparations. This technique permits simultaneous visualization of the endothelium and assessment of functional responses (contraction and dilation) and was used so that we could confirm the removal of the endothelium as required.

Arteries of 200--230 μm diameter were loaded with Cal‐520/AM as above, except that they were pinned to the bottom of a custom, Sylgard‐coated flow chamber. This flow chamber was designed to facilitate the perfusion of solutions (1.5 ml·min^−1^) when mounted on an upright microscope (FN‐1, Nikon, Tokyo, Japan). Handling and pinning of the arteries were restricted to the outermost corners, leaving the central portion of the vessels with intact endothelium and able to contract/dilate freely.

Following incubation, arteries were gently washed with PSS and left to equilibrate for 30 min in PSS (continuously perfused 1.5 ml·min^−1^ using a syringe pump). Contraction was stimulated by swapping the PSS for one containing [phenylephrine](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=485). The concentration of phenylephrine was titrated to contract arteries to \~20% of resting diameter. Relaxation was stimulated by changing the phenylephrine‐containing syringe for one containing phenylephrine (at the same concentration) and either ACh (100 nM), GSK1016790A (GSK, 20 nM), or [sodium nitroprusside](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9533) (SNP, 100 μM). Contractile and dilator responses were assessed before and after (paired) various treatments in the same artery, as described in the text. After treatment, antagonists were continuously present in the PSS. The removal of the endothelium was achieved by gentle mechanical disruption with a human hair that was superglued onto a pipette tip. Endothelium removal was confirmed by the absence of endothelial cells stained with the Ca^2+^ indicator Cal‐520/AM. After the removal of the endothelium, arteries were left to equilibrate for 60 min.

Images were acquired at 10 or 5 Hz (consistent within each experimental protocol) using an upright fluorescence microscope equipped with a 16× objective lens (0.8 NA; Nikon, Tokyo, Japan) and large format (1,024 × 1,024; 13‐μm pixels) back‐illuminated electron‐multiplying charge‐coupled device camera (iXon 888; Andor, Belfast, UK) and stored for offline analysis. An edge‐detection algorithm (Lawton et al., [2019](#bph14762-bib-0033){ref-type="ref"}) was used to track the width of arteries in image recordings. The algorithm extracts an intensity profile along a scanline orientated perpendicular to the longitudinal axis of the vessel. Each intensity profile was smoothed using a 251‐point, fifth‐order Savitzky--Golay filter, and the first‐order derivative calculated. The edges of the artery correspond to the maxima and minima of the first‐order derivative, which were identified and tracked using a zero‐crossing detector. The width of the artery equates to the unfolded circumference of the intact vessel and was converted to the equivalent diameter. To control for variation in the resting diameters, summary contractile response data are expressed as the percentage reduction from resting diameter,while relaxation responses are expressed as the percentage increase in diameter compared to resting diameter (Figure [S2](#bph14762-supitem-0002){ref-type="supplementary-material"}).

2.5. Matching arterial tone across experimental conditions {#bph14762-sec-0015}
----------------------------------------------------------

Following the removal of the endothelium, arteries were significantly more sensitive to phenylephrine. The concentration of phenylephrine was titrated to achieve a level of tone that was comparable to that achieved in the presence of a functional endothelium (Figure [S2A](#bph14762-supitem-0002){ref-type="supplementary-material"}). In the presence of [cyclopiazonic acid](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5350) (CPA), Phenylephrine‐induced contractions were transient, and it was not possible to achieve a stable contraction. Therefore, assessing the effect of store depletion on TRPV4‐induced dilation was not feasible. Instead, vessels were pretreated with GSK and CPA, and the magnitude of the transient contraction induced by phenylephrine was assessed. Furthermore, after depletion of Ca^2+^ stores using CPA, a significantly higher concentration of phenylephrine was required to generate comparable levels of vascular tone (Figure [S2B](#bph14762-supitem-0002){ref-type="supplementary-material"}).

2.6. Pressure myography {#bph14762-sec-0016}
-----------------------

Diameter measurements of pressurized arteries were performed using the VasoTracker open source pressure myograph system (system (RRID:SCR_017233; Lawton et al., [2019](#bph14762-bib-0033){ref-type="ref"}). Mesenteric arteries were dissected free from surrounding tissue, cleaned of connective tissue, and mounted on similar sized glass pipettes in a VasoTracker pressure myograph chamber. Arteries were pressurized to 70 mmHg, checked for leaks, and left to equilibrate for 30 min in pre‐warmed (37°C) circulating PSS, with intraluminal flow (\~100 μl·min^−1^) established by a 10 cmH~2~O pressure gradient.

Artery diameter was monitored using an sCMOS camera (DCC1545M, Thorlabs, New Jersey, USA) and recorded by VasoTracker acquisition software. Arteries were contracted using phenylephrine (\~500 nM) to \~80% of resting diameter, which was added to the perfusion solution. All other drugs (e.g., ACh and GSK) were applied intraluminally. Summary relaxation data are expressed as the percentage increase in diameter compared to resting diameter.

2.7. Materials {#bph14762-sec-0017}
--------------

Cal‐520/AM was obtained from Abcam (Cambridge, MA, USA). Caged‐IP~3~ (caged‐IP~3~ 4,5‐dimethoxy‐2‐nitrobenzyl) was obtained from Sichem (Germany). Pluronic F‐127 was obtained from Invitrogen (Carlsbad, CA, USA). U73343 was obtained from Tocris (St Louis, MO, USA). All other drugs and chemicals were obtained from Sigma (St Louis, MO, USA). GSK, [HC067047](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4213), CPA, [U73122](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5283), U73343, [2‐aminoethoxydiphenyl borate](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2433) (2‐APB), and ionomycin were dissolved in DMSO and diluted to working concentration in PSS such that the total volume of DMSO was less than or equal to 0.1%. All other drug stocks were dissolved in water. The PSS consisted of the following (mM): 145 NaCl, 4.7 KCl, 2.0 MOPS, 1.2 NaH~2~PO~4~, 5.0 glucose, 0.02 EDTA, 1.17 MgCl~2~, and 2.0 CaCl~2~ (adjusted to pH 7.4 with NaOH). In experiments using a Ca^2+^‐free PSS, Ca^2+^ was substituted with Mg^2+^ on an equimolar basis, and EGTA (1 mM) was included. All solutions were freshly prepared each day.

2.8. Data and statistical analysis {#bph14762-sec-0018}
----------------------------------

The data and statistical analysis in this study comply with the recommendations of the British Journal of Pharmacology on experimental design and analysis in pharmacology The *n* vales shown are the numbers of biological replicates (number of animals). For each replicate, a single field of endothelial cells (Ca^2+^ imaging experiments) or a single artery segment (vascular reactivity studies) was studied. Summary data are presented graphically as paired mean responses, or as the grand mean ± SEM of *n* biological replicates. Two‐tailed, paired t test (for paired observations), independent two‐sample *t* tests or repeated measures one‐way ANOVA with multiple comparisons were used as indicated in the text. All statistical analyses were performed using GraphPad Prism version 6.0 (RRID:SCR_002798; GraphPad Software, La Jolla, CA, USA). A *P* value of \<.05 was considered statistically significant.

2.9. Nomenclature of targets and ligands {#bph14762-sec-0020}
----------------------------------------

Key protein targets and ligands in this article are hyperlinked to corresponding entries in <http://www.guidetopharmacology.org>, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., [2018](#bph14762-bib-0026){ref-type="ref"}), and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander, Christopoulos et al., [2017](#bph14762-bib-0003){ref-type="ref"}; Alexander, Fabbro et al., [2017](#bph14762-bib-0004){ref-type="ref"}; Alexander, Peters et al., [2017](#bph14762-bib-0005){ref-type="ref"}; Alexander, Striessnig et al., [2017](#bph14762-bib-0006){ref-type="ref"}).

3. RESULTS {#bph14762-sec-0021}
==========

3.1. Characteristics of ACh‐ and GSK‐evoked Ca^2+^ signals {#bph14762-sec-0022}
----------------------------------------------------------

To determine if activation of TRPV4 channels in endothelial cells evoked Ca^2+^ release from the internal store, endothelial cells were loaded with the fluorescent Ca^2+^ indicator Cal520/AM and activated with ACh (100 nM) or the TRPV4 channel agonist GSK (20 nM). Ca^2+^ activity was then visualized in the fields of \~100 endothelial cells. Cellular responses were analysed individually (Figures [1](#bph14762-fig-0001){ref-type="fig"} and [S1](#bph14762-supitem-0002){ref-type="supplementary-material"}).

![ACh and GSK1016790A stimulate different Ca^2+^ signalling patterns. (a, b) Ca^2+^ dynamics visualized in a single en face endothelial preparation stimulated with ACh (a), and GSK1016790A (GSK, b). Panels show: (i) composite images illustrating endothelial Ca^2+^ activity over the time course of the experiment, scale bars = 50 μm; (ii) whole‐cell Ca^2+^ traces (F/F~0~) for all cells shown in the corresponding panel in (i) ranked and coloured according to the magnitude of the signal (dark blue, low; dark red, high); (iii) a representative Ca^2+^ trace from a single cell; (iv) a rolling summation (30 s) of the number of Ca^2+^ events (peaks) across the‐field of‐view; and (v) a rastergram display of Ca^2+^ activity, where each dot represents the occurrence of a peak in the Ca^2+^ response from each cell. (c) Representative images showing endothelial cells that were most sensitive (first 25% of endothelial cells to respond) to application of either ACh (green) or GSK (red). On average, 32.6% of cells that responded to one agonist also responded to the other (indicated by yellow in right most panel; n = 3). Scale bars = 20 μm](BPH-176-3297-g001){#bph14762-fig-0001}

Ca^2+^ responses evoked by ACh and GSK were clearly different (Figure [1](#bph14762-fig-0001){ref-type="fig"}). ACh evoked a rapid elevation in intracellular Ca^2+^ which was followed by asynchronous oscillations across the field of view (Figure [1](#bph14762-fig-0001){ref-type="fig"}; Mumtaz et al., [2011](#bph14762-bib-0052){ref-type="ref"}). Activation of TRPV4 channels resulted in heterogeneous Ca^2+^ responses (Figure [1](#bph14762-fig-0001){ref-type="fig"}c, [Movie S1](#bph14762-supitem-0003){ref-type="supplementary-material"}, and Figure [S3](#bph14762-supitem-0002){ref-type="supplementary-material"}) that consisted of several distinct phases (Figures [1](#bph14762-fig-0001){ref-type="fig"} and [2](#bph14762-fig-0002){ref-type="fig"}). The response to GSK was, initially, small localized Ca^2+^ spikes which led to a slowly increasing global cytoplasmic Ca^2+^ concentration (Figures [2](#bph14762-fig-0002){ref-type="fig"}b and [S4](#bph14762-supitem-0002){ref-type="supplementary-material"}). The GSK‐evoked, global Ca^2+^ elevation eventually plateaued, but the time taken to plateau was significantly longer when compared to ACh (Figure [1](#bph14762-fig-0001){ref-type="fig"}; 55.9 ± 6.4 s for GSK; 16.7 ± 4.7 s for ACh; *n* = 6). Finally, large propagating Ca^2+^ waves developed (Figure [2](#bph14762-fig-0002){ref-type="fig"}b,c and [Movies S1](#bph14762-supitem-0003){ref-type="supplementary-material"} and [S2](#bph14762-supitem-0004){ref-type="supplementary-material"}). These waves propagated within and between cells at a constant velocity of \~5 to 15 μm·s^−1^ (Figure [2](#bph14762-fig-0002){ref-type="fig"}b,c, [Movie S2](#bph14762-supitem-0004){ref-type="supplementary-material"}, and Figure [S5](#bph14762-supitem-0002){ref-type="supplementary-material"}). GSK‐evoked intracellular Ca^2+^ waves were significantly lower in frequency than those for ACh (0.05 ± 0.01 Hz for GSK; 0.22 ± 0.03 Hz for ACh; *n* = 6).

![Activation of TRPV4 channels stimulates local and propagating Ca^2+^ events. (a) Representative Ca^2+^ image (left), cell outlines (middle), and ΔF/F~0~ maximum intensity projection (right) illustrating the endothelial Ca^2+^ response to activation of TRPV4 channels with GSK1016790A (GSK; 20 nM). The ΔF/F~0~ image shows an increase in Ca^2+^ across the field of endothelial cells. (b) GSK stimulates local Ca^2+^ events and propagating Ca^2+^ waves. Panels show: (i) Ca^2+^ traces illustrating the effect of GSK on whole‐cell Ca^2+^ levels from cells indicated by the coloured outlines in (a); (ii) line scans (kymographs) showing GSK‐evoked local Ca^2+^ events (1) and propagating Ca^2+^ waves (2). Kymographs in (ii) correspond to the times indicated by dashed lines in (i) and were generated from F/F~Δt~ movies, where F~Δt~ is the running (20 s) baseline. (c) Ca^2+^ waves propagate across multiple cells. Panels show: (i) time series of the active front (determined by sequential subtraction) of a multicellular Ca^2+^ wave that spreads across four endothelial cells; (ii, iii) polar coordinate system (ii), example F/F~Δt~ radial line scans (iii, 20° integration angle), and polar plot (iv) showing the angular dependence of propagation distance/velocity for the depicted Ca^2+^ event. Data in (c) are shown in [Movie S2](#bph14762-supitem-0004){ref-type="supplementary-material"}. All scale bars = 20 μm](BPH-176-3297-g002){#bph14762-fig-0002}

These results suggest there are at least major two components of the Ca^2+^ signal arising from activation of TRPV4 channels: (a) initial local signals which lead to a slow global rise in Ca^2+^ and (b) large fast propagating Ca^2+^ waves.

We next sought to examine the mechanisms that give rise to the GSK‐evoked Ca^2+^ signals. We first confirmed the reproducibility of GSK‐evoked responses (20 nM) in the same preparation so that a paired experimental design could be used to examine the effects of blockers. There was no significant difference in any of the Ca^2+^ signal parameters measured (number of peaks, peak amplitudes, peak durations, 10--90% rise time, and 90--10% fall time) on repeated applications of GSK (Figure [S3](#bph14762-supitem-0002){ref-type="supplementary-material"}).

3.2. Ca^2+^ influx via TRPV4 channels is required to initiate endothelial Ca^2+^signals {#bph14762-sec-0023}
---------------------------------------------------------------------------------------

To examine the mechanisms underlying each component of the GSK‐evoked Ca^2+^ signal, we developed methods to extract the slow global rise in Ca^2+^ and the propagating Ca^2+^ waves (fast) component from raw Ca^2+^ signals in each cell (Figure [S1](#bph14762-supitem-0002){ref-type="supplementary-material"}).

To determine if each component is dependent on Ca^2+^ entry, we first performed experiments using a Ca^2+^‐free PSS (Figure [3](#bph14762-fig-0003){ref-type="fig"}a,b). The removal of extracellular Ca^2+^ significantly decreased the percentage of cells exhibiting "slow" global Ca^2+^ elevations and "fast" propagating waves in response to GSK (Figure [3](#bph14762-fig-0003){ref-type="fig"}c). The velocity of residual Ca^2+^ waves was similar to those occurring in the presence of external Ca^2+^ (Figure [3](#bph14762-fig-0003){ref-type="fig"}d; 10.0 ± 1.1 μm·s^−1^ for control; 8.8 ± 0.7 μm·s^−1^ for Ca^2+^‐free; *n* = 5). However, removal of external Ca^2+^ significantly reduced the amplitude (Figure [3](#bph14762-fig-0003){ref-type="fig"}e; 0.28 ± 0.11 ΔF/F~0~ for control; 0.02 ± 0.10 ΔF/F~0~ for Ca^2+^‐free; *n* = 6) and the frequency of occurrence (Figure [3](#bph14762-fig-0003){ref-type="fig"}f; 4.1 ± 0.6 peaks per cell for control; 1.7 ± 0.1 peaks per cell for Ca^2+^‐free; *n* = 6) of these residual propagating Ca^2+^ waves.

![The removal of extracellular Ca^2+^ abolishes GSK‐evoked Ca^2+^ signalling. (a) Composite images showing GSK1016790A (GSK)‐evoked Ca^2+^ activity in a single field of native mesenteric artery endothelial cells before (left, control) and after (right, Ca^2+^‐free) the removal of external Ca^2+^. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked (20 nM; grey box) cellular Ca^2+^ signals (F/F~0~) in the presence (left) and absence (right) of extracellular Ca^2+^. F/F~0~ signals (top) were decomposed into fast (middle) and slow (bottom) components. (c) Summary bar chart showing the percentage of cells that exhibited propagating Ca^2+^ waves (fast) and slow global Ca^2+^ elevations (slow). (d--f) Paired summary data showing the effect of external Ca^2+^ inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e and f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 6)](BPH-176-3297-g003){#bph14762-fig-0003}

These results suggest that Ca^2+^ influx across the plasma membrane is essential for the slow global increase in Ca^2+^ and for the propagating Ca^2+^ waves evoked by GSK.

To test whether or not the slow global Ca^2+^ rise and propagating Ca^2+^ waves evoked by GSK arose from the activation of TRPV4 channels, we pre‐incubated endothelial cells with the non‐selective TRPV channel antagonist, [ruthenium red](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2432) (RuR; 5 μm, 20 min; Figure [4](#bph14762-fig-0004){ref-type="fig"}a,b). RuR significantly reduced the percentage of cells responding to GSK with slow global Ca^2+^ elevations and propagating Ca^2+^ waves (Figure [4](#bph14762-fig-0004){ref-type="fig"}c). Pretreatment with RuR reduced the amplitude (Figure [4](#bph14762-fig-0004){ref-type="fig"}e; 0.33 ± 0.06 ΔF/F~0~ for control; 0.07 ± 0.01 ΔF/F~0~ for RuR; *n* = 6) and the frequency of occurrence (Figure [4](#bph14762-fig-0004){ref-type="fig"}f; 13.4 ± 3.3 peaks per cell for control; 3.2 ± 0.1 peaks per cell for RuR; *n* = 6) of propagating Ca^2+^ waves but had no effect on the velocity of propagating waves (Figure [4](#bph14762-fig-0004){ref-type="fig"}d; 11.8 ± 0.7 μm·s^−1^ for control; 11.6 ± 1.7 μm·s^−1^ for RuR; *n* = 5). A similar reduction in GSK‐evoked Ca^2+^ signalling was observed using the selective TRPV4 channel antagonist, HC067047 (HC067; 10 μM, 20 min; Figure [5](#bph14762-fig-0005){ref-type="fig"}a,b). HC067 reduced the percentage of cells exhibiting slow, global elevations and the percentage exhibiting fast, propagating Ca^2+^ waves (Figure [5](#bph14762-fig-0005){ref-type="fig"}c). HC067 reduced the amplitude (Figure [5](#bph14762-fig-0005){ref-type="fig"}e; 0.29 ± 0.08 ΔF/F~0~ for control; 0.08 ± 0.02 ΔF/F~0~ for HC067; *n* = 6) and the frequency (Figure [5](#bph14762-fig-0005){ref-type="fig"}f; 5.5 ± 0.8 peaks per cell for control; 0.7 ± 0.2 peaks per cell for HC067; *n* = 6) of propagating Ca^2+^ waves. The velocity of residual Ca^2+^ waves was unaffected by HC067 (Figure [5](#bph14762-fig-0005){ref-type="fig"}d; 13.1 ± 0.8 μm·s^−1^ for control; 13.6 ± 0.7 μm·s^−1^ for HC067; *n* = 5).

![Inhibition of TRPV channels with ruthenium red inhibits propagating Ca^2+^ waves and slow global Ca^2+^ elevations evoked by GSK1016790A. (a) Composite images showing GSK1016790A (GSK)‐evoked (20 nM) Ca^2+^ activity in the absence (left) and presence (right) of the broad‐spectrum TRPV channel antagonist ruthenium red (RuR; 5 μM, 20 min) in the same native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) Raw F/F~0~ (top), fast (middle), and slow (bottom) components of the GSK‐evoked (20 nM; grey box) Ca^2+^ signal in the absence (left) and presence (right) of RuR. (c) Summary bar chart illustrating the effect of RuR on the percentage of cells exhibiting propagating Ca^2+^ waves and slow global Ca^2+^ signal components. (d--f) Paired summary data showing the effect of TRPV channel inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e--f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 6)](BPH-176-3297-g004){#bph14762-fig-0004}

![Inhibition of TRPV4 channels with HC067047 inhibits both propagating Ca^2+^ waves and slow global Ca^2+^ elevations evoked by GSK1016790A. (a) Composite images showing GSK1016790A (GSK)‐evoked (20 nM) Ca^2+^ activity in the absence (left) and presence (right) of the broad‐spectrum TRPV channel antagonist HC067047 (HC067; 10 μM, 20 min) in the same native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) Raw F/F~0~ (top), fast (middle), and slow (bottom) components of the GSK‐evoked (grey box) Ca^2+^ signal in the absence (left) and presence (right) of HC067. (c) Summary bar chart illustrating the effect of HC067 on the percentage of cells exhibiting propagating Ca^2+^ waves and slow global Ca^2+^ signal components. (d--f) Paired summary data showing the effect of TRPV4 channel inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e--f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 6)](BPH-176-3297-g005){#bph14762-fig-0005}

Together, these results suggest that Ca^2+^ influx via TRPV4 channels is required to induce both the slow global rise component and the propagating Ca^2+^ waves induced by GSK.

3.3. GSK‐induced Ca^2+^waves require a replete internal Ca^2+^ store, IP~3~ synthesis, and IP~3~ receptor activation {#bph14762-sec-0024}
--------------------------------------------------------------------------------------------------------------------

Having confirmed a role for TRPV4‐mediated Ca^2+^ influx in GSK‐stimulated Ca^2+^ signals, we next investigated the contribution of the internal Ca^2+^ store using the sarcoplasmic/endoplasmic reticulum Ca^2+^ [‐ATPase](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=159) (SERCA) inhibitor, CPA (Figure [6](#bph14762-fig-0006){ref-type="fig"}a,b). Depletion of the internal store by CPA decreased the percentage of cells exhibiting the slow global rise component of the GSK‐evoked Ca^2+^ signal and the percentage of cells in which propagating Ca^2+^ waves occurred (Figure [6](#bph14762-fig-0006){ref-type="fig"}c). CPA significantly inhibited the wave propagation speed (Figure [6](#bph14762-fig-0006){ref-type="fig"}d; 8.6 ± 0.4 μm·s^−1^ for control; 3.6 ± 0.5 μm·s^−1^ for CPA; *n* = 6), amplitude (Figure [6](#bph14762-fig-0006){ref-type="fig"}e; 0.48 ± 0.12 ΔF/F~0~ for control; 0.17 ± 0.04 ΔF/F~0~ for CPA; *n* = 6), and frequency (Figure [6](#bph14762-fig-0006){ref-type="fig"}f; 4.3 ± 0.4 peaks per cell for control; 1.5 ± 0.2 peaks per cell for CPA; *n* = 6) of Ca^2+^ waves. The amplitude of the slow global Ca^2+^ rise initially appeared to be reduced by CPA (Figure [6](#bph14762-fig-0006){ref-type="fig"}b). However, this apparent decrease appears to occur in large part because of the increase in baseline Ca^2+^ evoked by CPA and the non‐linear relationship between Ca^2+^ concentration and F/F~0~ value. When the signals were calibrated (see Section [2](#bph14762-sec-0010){ref-type="sec"}), the mean Ca^2+^ concentration increase evoked by GSK was 123 ± 75 nM, but after CPA, GSK evoked a Ca^2+^ rise of 93 ± 44 nM (*n* = 3), showing no significant effect of CPA. CPA itself evoked an increase in Ca^2+^ concentration from a resting value of 176 ± 52 to 335 ± 58 nM (*n* = 3). The elevated Ca^2+^ may account for the reduced number of cells activated by GSK (Watanabe et al., [2003](#bph14762-bib-0084){ref-type="ref"}). These results suggest that the internal store is required for the propagating Ca^2+^ waves.

![Depletion of the internal Ca^2+^ store modifies the Ca^2+^ signal induced by activation of TRPV4 channels. (a) Composite images showing GSK1016709A (GSK)‐evoked Ca^2+^ activity in the absence (left) and presence (right) of cyclopiazonic acid (CPA; 10 μM, 5 min) in the same native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked (20 nM; grey box) cellular Ca^2+^ signals in the absence and presence of CPA (left and right respectively). Original F/F~0~ traces (top) were decomposed into fast (middle) and slow (bottom) components. CPA evoked a substantial increase in basal Ca^2+^ (see Section [3](#bph14762-sec-0021){ref-type="sec"}). In control and in the presence of CPA, F/F~0~ was normalized to the Ca^2+^ change before GSK so that the resting values in each case were 1. CPA caused a substantial increase in resting Ca^2+^ (see text). (c) Summary bar chart illustrating the effect of CPA on the percentage of cells exhibiting propagating Ca^2+^ waves and slow global Ca^2+^ elevations to GSK. (d--f) Paired summary data showing the effect of SERCA inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e--f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 6)](BPH-176-3297-g006){#bph14762-fig-0006}

To explore the role of Ca^2+^ release from the internal store, we examined the contribution of IP~3~ using pharmacological inhibition of [phospholipase C](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=274) (PLC; Figure [7](#bph14762-fig-0007){ref-type="fig"}a,b). The PLC inhibitor, U73122, significantly reduced the percentage of cells activated by GSK, both for the fast propagating Ca^2+^ waves and for the slow persistent Ca^2+^ elevation (Figure [7](#bph14762-fig-0007){ref-type="fig"}c). Although the mean amplitude of propagating Ca^2+^ waves was not significantly different in the presence of U73122 (1.32 ± 0.25 ΔF/F~0~ for control; 0.67 ± 0.14 for U73122; *n* = 5), there was a significant reduction in the propagation velocity (10.2 ± 0.4 μm·s^−1^ for control; 5.5 ± 0.7 μm·s^−1^ for U73122; *n* = 5) and frequency of those events (Figure [7](#bph14762-fig-0007){ref-type="fig"}d‐f).

![PLC inhibition reduces the slow global Ca^2+^ rises and propagating Ca^2+^ waves of the GSK‐evoked Ca^2+^ response. (a) Composite images illustrating GSK1016790A (GSK)‐evoked (20 nM) Ca^2+^ activity in the absence (left) and presence (right) of the PLC antagonist U73122 (2 μM, 10 min) in a single field of native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked F/F~0~ (top) Ca^2+^ signals, and corresponding fast (middle) and slow (bottom) signal components in the absence (left) and presence (right) of U73122. (c) Summary data showing the effect of U73122 on the percentage of endothelial cells exhibiting propagating Ca^2+^ waves (fast) and global Ca^2+^ elevations (slow). (d--f) Paired summary data showing the effect of PLC inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e--f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 5)](BPH-176-3297-g007){#bph14762-fig-0007}

U73343, the inactive analogue of the PLC inhibitor U73122, had no effect on GSK‐induced Ca^2+^ signals (Figure [S6](#bph14762-supitem-0002){ref-type="supplementary-material"}). The percentage of cells exhibiting slow and propagating Ca^2+^ wave components of the GSK‐evoked signal were unaltered. Pretreatment with U73343 did not significantly alter the propagation velocity (9.4 ± 0.4 μm·s^−1^ for control; 7.7 ± 0.3 μm·s^−1^ for U73343; *n* = 5), amplitude (1.34 ± 0.26 ΔF/F~0~ for control; 1.34 ± 0.14 for U73343; *n* = 5), nor the frequency (3.5 ± 0.3 peaks/cell for control; 4.3 ± 0.6 peaks/cell for U73343; *n* = 5) of propagating Ca^2+^ waves. Moreover, although U73122 inhibits the internal store Ca^2+^ pump in colonic smooth muscle cells (Macmillan & McCarron, [2010](#bph14762-bib-0039){ref-type="ref"}), the blocker did not reduce IP~3~‐evoked Ca^2+^ release in endothelial cells (Figure [S7](#bph14762-supitem-0002){ref-type="supplementary-material"}).

These results suggest that the GSK‐evoked slow global rise in Ca^2+^ and propagating Ca^2+^ waves each have contributions from PLC activation.

To investigate any role of IP~3~‐sensitive Ca^2+^ stores in propagating Ca^2+^ waves induced by activation of TRPV4 channels, we examined the effects of the IP~3~R antagonist, 2‐APB, on GSK‐evoked endothelial Ca^2+^ signalling (Figure [8](#bph14762-fig-0008){ref-type="fig"}). 2‐APB significantly reduced the percentage of cells exhibiting propagating Ca^2+^ waves but had no effect on the percentage of cells exhibiting slow global elevations in Ca^2+^ in response to GSK (Figure [8](#bph14762-fig-0008){ref-type="fig"}c). 2‐APB had no effect on the amplitude (0.67 ± 0.09 ΔF/F~0~ for control; 0.60 ± 0.15 ΔF/F~0~ for 2‐APB; *n* = 6) but significantly reduced propagation velocity (11.0 ± 0.8 μm·s^−1^ for control; 2.0 ± 0.4 μm·s^−1^ for 2‐APB; *n* = 5) and frequency (3.1 ± 0.3 peaks per cell for control; 0.9 ± 0.3 peaks per cell for 2‐APB; *n* = 6) of fast Ca^2+^ waves (Figure [8](#bph14762-fig-0008){ref-type="fig"}d--f).

![Inhibiting IP~3~ receptors prevents propagating Ca^2+^ waves but not slow global Ca^2+^ elevations induced by activation of TRPV4 channels. (a) Composite images showing Ca^2+^ activity evoked by GSK1016790A (GSK, 20 nM) in the absence (left) and presence (right) of the IP~3~R antagonist, 2‐APB (500 μM, 10 min) in a single field of native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca^2+^ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked (grey box) cellular Ca^2+^ signals (F/F~0~; top) were decomposed into fast (middle) and slow (bottom) components. (c) Summary data illustrating the percentage of cells exhibiting propagating Ca^2+^ waves and slow global Ca^2+^ increases. (d--f) Paired summary data showing the effect of IP~3~R inhibition on Ca^2+^ wave propagation velocity (d), peak amplitude (ΔF/F~0~, e), and the number of peaks per cell (f). The left plots in (e--f) are scatter plots showing the mean Ca^2+^ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. \*P \< .05, significantly different as indicated; paired Student\'s t test (n = 6)](BPH-176-3297-g008){#bph14762-fig-0008}

To crosscheck the contribution of IP~3~Rs in the propagating Ca^2+^ waves, we used caffeine---a potent inhibitor of IP~3~Rs (Ehrlich, Kaftan, Bezprozvannaya, & Bezprozvanny, [1994](#bph14762-bib-0016){ref-type="ref"}; Parker & Ivorra, [1991](#bph14762-bib-0061){ref-type="ref"}; Saleem, Tovey, Molinski, & Taylor, [2014](#bph14762-bib-0066){ref-type="ref"}). Caffeine, which does not evoke Ca^2+^ release in the endothelial cells under study and inhibits Ca^2+^ release evoked by IP~3~ (Wilson et al., [2019](#bph14762-bib-0089){ref-type="ref"}), also blocked GSK‐evoked propagating Ca^2+^ waves (Figure [S8](#bph14762-supitem-0002){ref-type="supplementary-material"}). Interestingly, caffeine also reduced the slow global Ca^2+^ rise suggesting an effect of caffeine also on TRPV4 channels.

While Ca^2+^ influx via TRPV4 channels triggered large propagating Ca^2+^ waves from the internal Ca^2+^ store, the release and influx did not become an uncontrolled self‐regenerative process but remained under the control of Ca^2+^ influx. When activation of TRPV4 channels ceases, by washout of GSK, the propagating Ca^2+^ waves stop (Figure [S9](#bph14762-supitem-0002){ref-type="supplementary-material"} and [Movie S3](#bph14762-supitem-0005){ref-type="supplementary-material"}), and Ca^2+^ returned towards resting values. This result demonstrates that TRPV4 channels maintain control of Ca^2+^ release from the internal Ca^2+^ store and the propagation of Ca^2+^ waves both within and between cells.

3.4. The functional effects of TRPV4 channels in controlling vascular tone {#bph14762-sec-0025}
--------------------------------------------------------------------------

Collectively, our results suggest that endothelial TRPV4‐mediated Ca^2+^ influx activates Ca^2+^‐induced Ca^2+^ release at IP~3~Rs. To investigate any physiological contribution of this process, we examined vascular tone in mesenteric arteries (Figure [8](#bph14762-fig-0008){ref-type="fig"}) with and without a functionally intact endothelial layer.

In intact, pressurized arteries, ACh and GSK each relaxed arteries and reversed phenylephrine‐mediated contractions (Figure [S10](#bph14762-supitem-0002){ref-type="supplementary-material"}; *n* = 5). Relaxations to GSK were reversed by the selective TRPV4 channel antagonist, HC067. However, the dilations to ACh were preserved after blockade of TRPV4 channels with HC067 (Figure [S10](#bph14762-supitem-0002){ref-type="supplementary-material"}; *n* = 5). These results suggest that these channels do not contribute to ACh‐evoked relaxations in rat mesenteric arteries (see also Hartmannsgruber et al., [2007](#bph14762-bib-0028){ref-type="ref"}; Kohler et al., [2006](#bph14762-bib-0031){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}).

We next investigated the contribution of the internal Ca^2+^ store to TRPV4‐mediated relaxation evoked by GSK. In *en face* preparations (225 ± 4 μm resting diameter; *n* = 10), ACh and GSK each relaxed phenylephrine‐constricted arteries back to pre‐constricted levels (Figure [9](#bph14762-fig-0009){ref-type="fig"} and Figure [S2](#bph14762-supitem-0002){ref-type="supplementary-material"}). In these same arteries, the removal of the endothelium increased the sensitivity to phenylephrine and significantly reduced relaxation to ACh (to 26 ± 7%; *n* = 5 vs. control with endothelium). The residual ACh‐evoked response may have arisen from the incomplete removal of the endothelium. The functional removal of the endothelium also prevented GSK‐evoked relaxations. Indeed, after the removal of the endothelium, GSK caused an increase in tone (Figure [9](#bph14762-fig-0009){ref-type="fig"}e; *n* = 5). Endothelium removal did not prevent relaxation to the endothelium‐independent vasodilator SNP (Figure [9](#bph14762-fig-0009){ref-type="fig"}).

![ACh and GSK1016790A both cause endothelium‐dependent vasodilation. (a and b) The vasodilator effect of ACh (a; 100 nM) and GSK1016790A (b; GSK; 20 nM) on phenylephrine (PE)‐contracted arteries before (+ endothelium) and after the mechanical removal of the endothelium (− endothelium). After the removal of the endothelium, sodium nitroprusside (SNP) was used to test endothelium‐independent vasodilation. Panels show: (i) images of an en face artery, illustrating the vessel\'s responses to phenylephrine and either ACh or GSK (in the continued presence of phenylephrine ); (ii) full time course of the experiments shown in the corresponding panel (i); (iii) Summary data (mean ± SEM, n = 5) illustrating the effect of the endothelium removal on vasodilator responses to the indicated agonist. Relaxations are expressed as % change from PE‐induced tone. A negative value indicates an enhancement of phenylephrine‐induced contraction. Coloured arrows in (ii) indicate the time at which relaxation to each agonist was assessed. All scale bars = 100 μm. \*P \< .05, significantly different as indicated; repeated measures one‐way ANOVA with multiple comparison](BPH-176-3297-g009){#bph14762-fig-0009}

These results demonstrate that vascular relaxation to GSK occurs via an endothelium‐dependent mechanism and not by acting directly on the underlying smooth muscle.

3.5. Store dependence of the TRPV4 channel response {#bph14762-sec-0026}
---------------------------------------------------

We next examined the contribution of Ca^2+^‐induced Ca^2+^ release at IP~3~Rs in TRVP4 mediated relaxation. To do this, we assessed the effect of GSK on vascular reactivity before and after depletion of internal Ca^2+^ stores.

Depletion of the internal Ca^2+^ store using CPA (6 μM) prevents stable contractions such that it was not possible to reliably assess vasodilator responses in these arteries. Instead, we examined whether pretreatment with GSK was capable of modulating PE‐evoked contraction (Figure [10](#bph14762-fig-0010){ref-type="fig"}). Pretreatment with GSK significantly attenuated PE‐induced contractions (Figure [10](#bph14762-fig-0010){ref-type="fig"}a, c).

![Ca^2+^ store depletion prevents TRPV4‐mediated opposition of vascular tone. (a and b) Effect of GSK1016790A (GSK, 20 nM) on phenylephrine (PE)‐induced contraction in vessels with an intact internal Ca^2+^ store (a) or after depletion of the internal Ca^2+^ store (b) using cyclopiazonic acid (CPA; 6 μm; bottom trace). Upper panels show images of en face arteries, pretreated with the indicated drug, before and after exposure to phenylephrine. Corresponding diameter traces are shown in the lower panels. Data in (i) and (ii) show responses from the same artery. Pretreatment with CPA and GSK consistently delayed the onset but increased the magnitude of the response to phenylephrine. The reason for the delay is not clear. All scale bars = 100 μm. (c) Summary data (mean ± SEM, n = 5) showing the magnitude of phenylephrine‐induced contraction (% resting diameter) under each of the conditions. Diameter measured at the times indicated by the red arrows on diameter traces. \*P \< .05, significantly different as indicated; repeated measures one‐way ANOVA with multiple comparisons](BPH-176-3297-g010){#bph14762-fig-0010}

After Ca^2+^ store depletion using CPA, a higher concentration of phenylephrine (3.6 ± 0.2 μM for control; 12.8 ± 2.2 μM for CPA; *n* = 5) was required to achieve a level of contraction (20 ± 2%; *n* = 5) equivalent to control conditions (Figure [S2](#bph14762-supitem-0002){ref-type="supplementary-material"}). After store depletion with CPA, pretreatment with GSK no longer attenuated phenylephrine‐induced contraction (4 ± 2% contraction for GSK; 27 ± 6% contraction for GSK + CPA; *n* = 5; *P* \< .05). Rather, GSK tended to enhance the contraction to phenylephrine (Figure [10](#bph14762-fig-0010){ref-type="fig"}b, c). Together, these results demonstrate that depletion of internal Ca^2+^ stores reduces the inhibitory effect of GSK pretreatment on phenylephrine‐induced contraction.

4. DISCUSSION {#bph14762-sec-0027}
=============

TRPV4 channels are emerging as key plasmalemmal channels that mediates Ca^2+^ influx and physiological functions in the endothelium (Fiorio Pla et al., [2012](#bph14762-bib-0019){ref-type="ref"}; Gao & Wang, [2010](#bph14762-bib-0022){ref-type="ref"}; Gifford et al., [2014](#bph14762-bib-0024){ref-type="ref"}; Ma et al., [2013](#bph14762-bib-0038){ref-type="ref"}; Sayed et al., [2010](#bph14762-bib-0067){ref-type="ref"}; Schierling et al., [2011](#bph14762-bib-0068){ref-type="ref"}; Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}; Thodeti et al., [2009](#bph14762-bib-0077){ref-type="ref"}; Troidl et al., [2009](#bph14762-bib-0080){ref-type="ref"}). We have shown that the Ca^2+^ increase in endothelial cells, arising from Ca^2+^ entry via TRPV4 channels, may be amplified by a Ca^2+^‐induced Ca^2+^ release‐like mechanism acting at IP~3~Rs to generate propagating Ca^2+^ waves. When IP~3~R‐mediated Ca^2+^ release was inhibited, TRPV4‐induced increases in intracellular \[Ca^2+^\] and TRPV4‐mediated control of vascular tone was supressed. These results highlight the significance of endothelial TRPV4‐mediated Ca^2+^‐induced Ca^2+^ release at IP~3~Rs in controlling vascular contractility (Figure [11](#bph14762-fig-0011){ref-type="fig"}).

![Model of TRPV4‐mediated control of vascular tone. Activation of TRPV4 channels (1) induces Ca^2+^ influx which results in a persistent elevation in cytoplasmic Ca^2+^ concentration (2). Basal (Hardie, Gu, Martin, Sweeney, & Raghu, [2004](#bph14762-bib-0025){ref-type="ref"}; Running Deer, Hurley, & Yarfitz, [1995](#bph14762-bib-0064){ref-type="ref"}; Willars, Nahorski, & Challiss, [1998](#bph14762-bib-0087){ref-type="ref"}) or Ca^2+^‐activated PLC (γ, δ, or β) activity decreases PIP~2~ and generates IP~3~ (3). Ca^2+^ derived from TRPV4 channel activity together with IP~3~ (McCarron, Chalmers, MacMillan, & Olson, [2010](#bph14762-bib-0044){ref-type="ref"}) act at IP~3~ receptors on the internal Ca^2+^ store to induce Ca^2+^ release (4). The released Ca^2+^ triggers propagating Ca^2+^ waves (5) by activating neighbouring IP~3~ receptors that ultimately result in vasodilation (6). The entire process remains under the control of Ca^2+^ influx and terminates when TRPV4 channel activity ceases. This channel activity is suppressed by PIP~2~ (7). ACh, via the [M3 receptor](http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15), also activates PLC to generate IP~3~ and activate Ca^2+^ release from the store. The characteristics of M~3~‐ and TRPV4‐mediated Ca^2+^ release differ significantly (see text)](BPH-176-3297-g011){#bph14762-fig-0011}

In this study, we analysed individual TRPV4‐mediated Ca^2+^ responses in large numbers of endothelial cells in intact blood vessels. Two components, a slow global increase and propagating Ca^2+^ waves, contributed to the Ca^2+^ response to activation of TRPV4 channels. The response to activation of TRPV4 channels was also heterogeneous among cells. Some cells were highly responsive, while other cells responded weakly or not at all (see also Aird, [2012](#bph14762-bib-0002){ref-type="ref"}; Huang, Chu, Chen, & Jen, [2000](#bph14762-bib-0030){ref-type="ref"}; Lee et al., [2018](#bph14762-bib-0034){ref-type="ref"}; Marie & Beny, [2002](#bph14762-bib-0041){ref-type="ref"}; McCarron, Lee, & Wilson, [2017](#bph14762-bib-0045){ref-type="ref"}; McCarron et al., [2019](#bph14762-bib-0047){ref-type="ref"}; Wilson, et al., [2016](#bph14762-bib-0091){ref-type="ref"}). We developed methods to automatically extract and separate the slow global increases and propagating Ca^2+^ waves occurring in each endothelial cell. The changes in Ca^2+^ concentration triggered by activation of TRPV4 channels consisted of different phases which operated sequentially. First, rapid localized Ca^2+^ changes occurred which led to a slow persistent global elevation in Ca^2+^ throughout the cytoplasm. Then, large transient increases as a result of propagating Ca^2+^ waves occurred. The large transient increases as a result of propagating Ca^2+^ waves dominated the Ca^2+^ changes occurring in the endothelium after a short time (\~30 s).

Each of the Ca^2+^ changes occurring as a result of activation of TRPV4 channels was critically dependent on Ca^2+^ influx across the plasma membrane. The Ca^2+^ changes were abolished after the removal of external Ca^2+^ or by the inhibition of TRPV4 channels, with RuR or HC067047. These results suggest that Ca^2+^ influx via TRPV4 channels generates the persistent global Ca^2+^ rise. Inhibiting IP~3~‐mediated Ca^2+^ release by depleting the internal Ca^2+^ store, or inhibiting IP~3~Rs, had little effect on the slow persistent global elevation in Ca^2+^ but prevented the large transient increases arising from propagating Ca^2+^ waves. This result suggests that Ca^2+^ entry via TRPV4 channels triggers activation of IP~3~Rs which amplifies the initial Ca^2+^ rise and initiates regenerative release of Ca^2+^ in the form of propagating waves. In support of the active nature of the Ca^2+^ waves, the velocity of wave progression away from the release site was relatively constant within and between cells (\~5 to 15 μm·s^−1^). If diffusion alone was responsible for wave progression, velocity and amplitude would decline with distance from the release site. The mechanisms contributing to TRPV4‐mediated activation of Ca^2+^ release and propagation may include direct activation of IP~3~Rs (in a Ca^2+^‐induced Ca^2+^ release like process) or indirect Ca^2+^‐dependent activation of PLC. The partial inhibition of the propagating Ca^2+^ waves by the PLC‐blocker, U73122, is consistent with being a Ca^2+^‐induced Ca^2+^ release‐like process at IP~3~Rs. Basal PLC activity has been reported for many PLC isoforms in biochemical experiments (Running Deer et al., [1995](#bph14762-bib-0064){ref-type="ref"}; Willars et al., [1998](#bph14762-bib-0087){ref-type="ref"}) and in living cells (Hardie et al., [2004](#bph14762-bib-0025){ref-type="ref"}; Willars et al., [1998](#bph14762-bib-0087){ref-type="ref"}) which may create a background level of IP~3~ for Ca^2+^‐induced Ca^2+^ release to occur.

Interestingly, blocking of PLC by U73122 also reduced the slow global Ca^2+^ response (i.e., TRPV4‐mediated Ca^2+^ influx). Previous work has shown that TRPV4 channels are inhibited by the phospholipid, [phosphatidylinositol 4,5‐bisphosphate](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2387) (PIP~2~; Harraz, Longden, Hill‐Eubanks, & Nelson, [2018](#bph14762-bib-0027){ref-type="ref"}). PLC‐mediated depletion of PIP~2~ results in disinhibition of TRPV4 channels and increased Ca^2+^ influx (Harraz et al., [2018](#bph14762-bib-0027){ref-type="ref"}). Thus, blocking of PLC by U73122 might be expected to decrease TRPV4 channel activity.

To block IP~3~Rs, we used both 2‐APB and caffeine. 2‐APB is a broad‐spectrum inhibitor that, although effective in blocking IP~3~Rs in native endothelial cells, may inhibit Ca^2+^ entry pathways (see Peppiatt et al., [2003](#bph14762-bib-0062){ref-type="ref"}; Trebak, Bird, McKay, & Putney, [2002](#bph14762-bib-0079){ref-type="ref"}; Voets et al., [2001](#bph14762-bib-0081){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}). However, in the present experimental conditions, 2‐APB did not reduce the slow global Ca^2+^ rise evoked by activation of TRPV4 channels suggesting that it is not inhibiting influx in the present experiments. Caffeine, while often used as a RyR activator, is a potent inhibitor of IP~3~Rs in the same concentration range used to activate RyR (Ehrlich et al., [1994](#bph14762-bib-0016){ref-type="ref"}; Parker & Ivorra, [1991](#bph14762-bib-0061){ref-type="ref"}; Saleem et al., [2014](#bph14762-bib-0066){ref-type="ref"}). Caffeine does not evoke Ca^2+^ release in endothelial cells (Wilson, Saunter, Girkin, & McCarron, [2015](#bph14762-bib-0090){ref-type="ref"}) and inhibits Ca^2+^ release induced by photolysis of caged‐IP~3~ in the endothelium (Wilson et al., [2019](#bph14762-bib-0089){ref-type="ref"}). That caffeine was effective in inhibiting propagating Ca^2+^ waves supports the conclusion that IP~3~Rs contribute to TRPV4‐mediated Ca^2+^ responses.

RuR and HC067047 were each used to block TRPV4 channels. RuR is an effective TRPV4 channel antagonist but also has effects unrelated to this channnel. For example, RuR is an antagonist of channels such as the mitochondrial uniporter, the RyR, voltage‐dependent Ca^2+^ channels, and other TRP channels. However, the effects of RuR on these other channels are unlikely to explain the present findings. RuR is not membrane permeant and will not have access to the cytoplasm, so the effects on the mitochondrial uniporter or RyR are unlikely to be of significance in the present study. While RuR may have effects on voltage‐sensitive Ca^2+^ channels (Cibulsky & Sather, [1999](#bph14762-bib-0013){ref-type="ref"}), these channels do not appear to play a major role in endothelial Ca^2+^ signalling. RuR may also inhibit other [TRP channels](http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=78), for example, TRPC and TRPA. However, those channels are not activated by the agonist used in the present study---GSK1016790A---suggesting that channels other than TRPV4 are unlikely contributors. The present findings with RuR are also supported by the use of the more selective TRPV4 channel antagonist HC067047 which also blocked the response to GSK1016790A. Together, the findings point to TRPV4 channels as being the major target for RuR in the present study.

The increase in cytoplasmic Ca^2+^ concentration evoked by TRPV4‐mediated Ca^2+^‐induced Ca^2+^ release at IP~3~Rs is large and regenerative, as demonstrated by the long distance propagation. This process arises (at least in part) because IP~3~Rs are activated by Ca^2+^. TRPV4 channels are also activated by Ca^2+^ (Strotmann, Schultz, & Plant, [2003](#bph14762-bib-0072){ref-type="ref"}). The Ca^2+^‐dependent processes operating at IP~3~Rs and TRPV4 channels are positive feedback mechanisms that should self‐reinforce and reach a maximum in all‐or‐none fashion. However, TRPV4‐mediated Ca^2+^‐induced Ca^2+^ release at IP~3~Rs does not become uncontrolled and, while regenerative, remains tightly regulated by Ca^2+^ influx. The question arises as to why maximum responses do not occur each time TRPV4‐mediated influx begins. The answer may lie in IP~3~Rs and TRPV4 channels being regulated to prevent uncontrolled influx and release (Foskett, White, Cheung, & Mak, [2007](#bph14762-bib-0020){ref-type="ref"}; Nilius, Watanabe, & Vriens, [2003](#bph14762-bib-0056){ref-type="ref"}). Two observations support this conclusion. First, when TRPV4‐mediated Ca^2+^ influx ceases, the release of Ca^2+^ from IP~3~Rs stops. Thus, Ca^2+^ release is tightly coupled to influx. Second, coordinated activity of IP~3~Rs is required for propagating waves to occur. The propagation of Ca^2+^ waves requires sequential opening and then closing of IP~3~Rs. Thus, after activation, the IP~3~R must become refractory to ensure a directional propagation of the signal. The decline in Ca^2+^ occurring at the back of the wave presumably follows from a functional compartmentalization of the endoplasmic reticulum which renders the site of IP~3~‐mediated Ca^2+^ release refractory to the phosphoinositide. The functional compartmentalization may arise from a lowered local Ca^2+^ concentration in the lumen of the endoplasmic reticulum, or increased Ca^2+^ concentrations could deactivate the receptors (Adkins & Taylor, [1999](#bph14762-bib-0001){ref-type="ref"}; McCarron, MacMillan, Bradley, Chalmers, & Muir, [2004](#bph14762-bib-0046){ref-type="ref"}; Oancea & Meyer, [1996](#bph14762-bib-0058){ref-type="ref"}). These observations highlight a system that is activated by Ca^2+^ influx, but is regulated to prevent an uncontrolled positive feedback processes dominating the TRPV4‐mediated increases in cytoplasmic Ca^2+^ concentrations.

As well as propagating at a constant velocity within cells, TRPV4‐mediated Ca^2+^ waves could move seamlessly, at the same velocity, across cell boundaries into neighbouring cells as intercellular Ca^2+^ waves ([Movie S2](#bph14762-supitem-0004){ref-type="supplementary-material"}). These waves were abolished by IP~3~R blockers or removal of GSK. The mechanisms of intercellular wave propagation are not entirely clear, but IP~3~Rs and (since the process stops when GSK is removed) TRPV4 channel activities are both required for these intercellular waves to occur.

In other tissues, intercellular Ca^2+^ waves may be a fundamental mechanism for coordinating multicellular responses (Leybaert & Sanderson, [2012](#bph14762-bib-0035){ref-type="ref"}). In the endothelium of small arteries of the mouse cremaster muscle, rapidly spreading intercellular Ca^2+^ waves propagate at a velocity of ∼116 μm·s^−1^ for distances up to ∼1 mm (Tallini et al., [2007](#bph14762-bib-0075){ref-type="ref"}). These intercellular waves are associated with vasodilation and are hypothesized to regulate blood flow to the parenchyma by inducing upstream dilation of arterioles (Tallini et al., [2007](#bph14762-bib-0075){ref-type="ref"}). The intercellular waves observed in the present study had a slower velocity (\~5 to 15 μm·s^−1^) than those in mouse cremaster arterioles, suggesting a different physiological control mechanism.

In previous studies, when endothelial IP~3~R‐mediated signalling was eliminated by depletion of the internal Ca^2+^ store, activation of TRPV4 channels induced a large but highly localized (few square micrometres) increase in Ca^2+^ concentrations (Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}). These localized Ca^2+^ signals were reported to activate endothelial Ca^2+^‐activated K^+^ channels (Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}) and lead to endothelial hyperpolarization and vasodilation (Sonkusare et al., [2012](#bph14762-bib-0070){ref-type="ref"}). However, activation of TRPV4 channels is known to also control the orientation of endothelial cells, regulate endothelial permeability, and modulate the production of antithrombotic factors, each of which may require a more global \[Ca^2+^\] increase throughout the cytoplasm (Noren et al., [2016](#bph14762-bib-0057){ref-type="ref"}; Phuong et al., [2017](#bph14762-bib-0063){ref-type="ref"}; Thodeti et al., [2009](#bph14762-bib-0077){ref-type="ref"}; Thoppil et al., [2016](#bph14762-bib-0078){ref-type="ref"}). In the present study, IP~3~R‐mediated Ca^2+^ release generated propagating Ca^2+^ waves and provided a mechanism by which TRPV4 channel activity, in the presence of a functioning Ca^2+^ store, may generate large rises in Ca^2+^ throughout the cytoplasm. These propagating waves are critical for TRPV4‐mediated control of vascular tone. When Ca^2+^ release from the internal store is inhibited, TRPV4‐mediated endothelial control of tone is abolished (Figure [10](#bph14762-fig-0010){ref-type="fig"}). This result suggests that control of vascular tone by TRPV4 channels is mediated by Ca^2+^‐induced Ca^2+^ release via IP~3~Rs. It is tempting to also speculate that the more general rise in Ca^2+^ throughout the cells, which occurs as a result of the propagating IP~3~R mediated Ca^2+^ waves, will facilitate TRPV4‐mediated control of endothelial permeability and the production of antithrombotic factors (Noren et al., [2016](#bph14762-bib-0057){ref-type="ref"}; Phuong et al., [2017](#bph14762-bib-0063){ref-type="ref"}; Thodeti et al., [2009](#bph14762-bib-0077){ref-type="ref"}; Thoppil et al., [2016](#bph14762-bib-0078){ref-type="ref"}).

ACh evoked rapid asynchronous Ca^2+^ waves in neighbouring endothelial cells. ACh‐evoked changes in intracellular Ca^2+^ concentration are linked closely to the IP~3~‐sensitive Ca^2+^ store, but they do not involve TRPV4 channels in rat arteries (Hartmannsgruber et al., [2007](#bph14762-bib-0028){ref-type="ref"}; see also Kohler et al., [2006](#bph14762-bib-0031){ref-type="ref"}; Wilson, Lee, & McCarron, [2016](#bph14762-bib-0088){ref-type="ref"}; Figure [10](#bph14762-fig-0010){ref-type="fig"}). While the response to the activation by ACh and activation of TRPV4 channels each involved IP~3~, the Ca^2+^ signals generated had very different characteristics. ACh‐evoked Ca^2+^ increases did not appear to coordinate between cells. Activation of TRPV4 channels evoked a slowly increasing baseline and large propagating Ca^2+^ waves.

Endothelial TRPV4 channels are involved in several cardiovascular control mechanisms, including inhibiting vasoconstriction in small skeletal muscle arteries in response to increases in temperature (Gifford et al., [2014](#bph14762-bib-0024){ref-type="ref"}), regulating myogenic tone (Bagher et al., [2012](#bph14762-bib-0007){ref-type="ref"}), remodelling of the cytoskeleton and reorientation of the endothelial cells in response to mechanical forces (Thodeti et al., [2009](#bph14762-bib-0077){ref-type="ref"}), collateral vessel growth (Sayed et al., [2010](#bph14762-bib-0067){ref-type="ref"}; Schierling et al., [2011](#bph14762-bib-0068){ref-type="ref"}; Troidl et al., [2009](#bph14762-bib-0080){ref-type="ref"}), and arachidonic acid‐induced endothelial cell migration required for angiogenesis (Fiorio Pla et al., [2012](#bph14762-bib-0019){ref-type="ref"}). The present results show that when the internal IP~3~ sensitive store is intact, TRPV4 channel activity evokes IP~3~R signalling to generate Ca^2+^ waves that propagate within and between cells, and through the Ca^2+^ store, TRPV4 channels modulate vascular contractility. The results demonstrate a link between TRPV4 channel activity and Ca^2+^‐induced Ca^2+^ release at IP~3~R in endothelial cells and offer a new target for drug development.
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Figure S1: Extraction of Ca2+ signals from raw data. A) Ca2+ image displaying a field of 97 native mesenteric artery endothelial cells. The centre of each cell is marked with a red dot. B) F/F0 Ca2+ traces for each of the cells identified in (A). The baseline region (red) was automatically identified for each cell, a trace from a single cell is highlighted in bold. C‐E) To extract signalling metrics, fast and slow Ca2+ signal components were extracted from F/F0 traces. C) Example of Ca2+ signal de‐multiplexing for the cellular trace (\#57) highlighted in B. The time‐dependent baseline (slow component, blue) of the F/F0 signal (black) was calculated using an asymmetric least‐squares (ALS) function, and modelled by a sigmoid function (green). The fast component of the signal (red) was isolated by dividing the F/F0 signal by the ALS signal. D) Sigmoid function, used to extract the rise time of the slow signal component, and fast signal component (shown in C) shown on an expanded time scale. Peaks were identified in the fast signal using an automated peak detection algorithm. E) Original F/F0, de‐multiplexed signal components, and sigmoid fits for each of the signals shown in B. Each trace is coloured according to the magnitude of the ALS signal, mean signal is overlaid in black.

Figure S2: ACh and GSK dilate PE‐constricted mesenteric arteries. A) Mean PE‐contracted vessel diameter (% of resting, left) and corresponding concentration of PE (right), before (+ endothelium) and after (‐ endothelium) mechanical removal of the endothelium (n = 10). B) Mean PE‐contracted vessel diameter (% of resting, left) and corresponding concentration of PE (right), in the absence (‐) and presence (+) of cyclopiazonic acid (CPA; 6 μM; n = 5). C) Summary data showing the effect of ACh (blue) and GSK (red) on the diameter of PE‐constricted arteries. Statistical analyses were performed using paired Student\'s t‐test (A), unpaired Student\'s t‐test (B) and repeated measures one‐way ANOVA with multiple comparisons (C). \* = p \< 0.05.

Figure S3: Repeat application of GSK elicits reproducible Ca2+ signals. A) Schematic of the experimental protocol. Mesenteric artery endothelial cells were subjected to perfusion with GSK1016790A (GSK; 20 nM) prior to washing, and a second application of GSK (20 nM). B) Composite images showing basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Ca2+ activity was derived from the 120 sec periods indicated by the numbered arrows in A. Scale bars = 50 μm. C) GSK‐evoked Ca2+ signals for the 1st (left) and 2nd (right) application of GSK. D) GSK‐evoked Ca2+ signalling parameters. Upper panels show the mean response for individual cells (grey dots) for a single experiment. The experimental mean is overlaid in red or blue. Lower panel show paired summary data (grand mean) for all experimental replicates. Parameters extracted include: the percentage of cells activated, the mean ΔF/F0 of Ca2+ peaks, the number of peaks detected per cell (peaks/cell), the amplitude of the fitted sigmoid, as well as the duration, rise time, fall time, area under the curve (AUC) of all Ca2+ signal peaks. \* p \< 0.05 (n=13) using paired Student\'s t‐test.

Figure S4: TRPV4‐mediated local Ca2+ activity. A) Local Ca2+ events elicited by GSK101679A (GSK; 20 nM). Panels show a ΔF/F0 time series of a single endothelial cell. Ca2+ events initiate at, but remain localized within, either end of the cell. Scale bars = 20 μm. B) Ca2+ traces from the entire cell (red) or from circular ROIs (\~2.5 μm diameter) positioned at each of the Ca2+ event initiation sites. Local Ca2+ events are inconsistently reflected in global (whole‐cell) Ca2+ traces.

Figure S5: Acetylcholine and GSK101679A stimulate different patterns of signalling across multiple cells. Left; Image showing the basal Cal‐520/AM fluorescence (grey) in a field of mesenteric artery endothelial cells. Scale bar = 50 μm. A transect (x‐y) was drawn through three adjoining cells (1‐3). Right) Ca2+ signals (F/F0) and kymographs illustrating Cal‐520/AM fluorescence (F) along the transect (x‐y; vertical axis) for cells 1‐3, when stimulated with acetylcholine (ACh; 100 nM; upper right) and then, after washout and recovery, GSK101679A (GSK; 20 nM; lower right). Traces are coloured according to the assigned cell number and kymographs are coloured on a scale where dark blue = min F and dark red = max F.

Figure S6: U73343, the inactive analogue of U73122, did not alter GSK induced Ca2+ signals. A) Composite images showing GSK1016790A (GSK)‐evoked Ca2+ activity in the absence (left) and presence (right) of U73343 (2 μM; 10 mins), the inactive analogue of the PLC inhibitor U73122 (Figure 6). Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. B) GSK‐evoked (20 nM; grey box) Ca2+ signals (F/F0; top) were decomposed into propagating Ca2+ waves (fast; middle) and slow global Ca2+ rise (slow; bottom) components. C) Summary data illustrating the percentage of cells displaying propagating Ca2+ waves and slow global Ca2+ rises. D‐F) Paired summary data showing the effect of U73343 on Ca2+ wave propagation velocity (D), peak amplitude (ΔF/F0, E) and the number of peaks per cell (F). The left plots in E‐F are scatter plots showing the mean Ca2+ event amplitude, or oscillation frequency, within each cell visualised in the experiment shown in panels A‐B. Individual data points are coloured (from blue, low to red, high) according to the density (i.e. occurrence) of particular values. \* p \< 0.05 using paired Student\'s t‐test (n = 5).

Figure S7: U73122 does not alter IP3‐mediated Ca2+ signals. A) Composite image (max F/F0 intensity projection) illustrating the Ca2+ response to photolysis of caged‐IP3 in the absence (upper) and presence (lower) of U73122 (2 μM, 10 mins). B) Whole‐cell Ca2+ traces extracted from the data shown in A. C) Summary data showing the effect of U73122 on the peak amplitude and number of cells that responded to photorelease of caged IP3. Each data point indicates the mean from a single field of endothelial cells (one animal). \*, p \< 0.05; NS, no statistically significant difference detected (i.e. p \> 0.05) using paired t test. Scale bars = 10 μm.

Figure S8: Caffeine inhibits propagating Ca2+ waves induced by TRPV4 activation. A) Composite images showing GSK1016790A (GSK)‐evoked Ca2+ activity in native mesenteric artery endothelial cells in the absence (left) and presence of caffeine (10 mM; right). Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. B) Raw F/F0 (top), propagating Ca2+ waves (fast; middle), and slow Ca2+ rises (slow; bottom) GSK‐evoked (20 nM; grey box) Ca2+ signal components in the absence (left) and presence (right) of caffeine. C) Summary data illustrating the percentage of cells exhibiting fast and slow signal components. D‐F) Paired summary data showing the effect of IP3R inhibition on Ca2+ wave propagation velocity (D), peak amplitude (ΔF/F0, E) and the number of peaks per cell (F). The left plots in E‐F are scatter plots showing the mean Ca2+ event amplitude, or oscillation frequency, within each cell visualised in the experiment shown in panels A‐B. Individual data points are coloured (from blue, low to red, high) according to the density (i.e. occurrence) of particular values. \* p \< 0.05 using paired Student\'s t‐test (n = 5).

Figure S9: GSK‐evoked Ca2+ signalling returns towards basal levels during a washout period. Ca2+ signals (F/F0; top) extracted from mesenteric artery endothelial cells stimulated with GSK1016790A (GSK; 20 nM). When GSK was washed out, signals returned to resting levels. Composite images (bottom) showing basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Ca2+ activity was derived from the 60 sec periods indicated by the dashed lines. Scale bars = 50 μm.

Figure S10: Acetylcholine (ACh) evoked relaxation is independent of TRPV4 in rat mesenteric arteries. (A) Representative diameter trace of a second order mesenteric artery (60 mmHg; luminal flow rate \~100 μl/min) in response to ACh or GSK. Upon exposure to PE (\~500 nM; duration indicated by the bar above the trace), vessels contracted and underwent vasomotion. Upon subsequent exposure to ACh (100 nM), arteries relaxed back towards resting diameter. On wash‐out of ACh, arteries contracted again. GSK (20 nM) also relaxed arteries back towards resting diameter. Dilation to GSK was reversed by the TRPV4 antagonist, HC067047 (10 μM). However, HC067047 did not prevent dilation to ACh. (B) Example images from the artery in A showing the artery prior to PE exposure (basal), after PE, after ACh, after GSK, after GSK and HC067047, and after ACh with HC067047. The red horizontal lines are measurement scan lines created by Vasotracker (see Methods). (C) Summary data showing the percentage relaxation to ACh and GSK1016790A (GSK) in the absence (black bar) and present (open bar) of HC067047 (n=5; \* p\<0.05).
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Click here for additional data file.

###### 

Movie S1: Endothelial Ca2+ signalling evoked by GSK. The grey channel shows basal Ca2+ levels,while the red channel shows Ca2+ activity (red, determined by sequential subtraction) evoked by the TRPV4 agonist, GSK1016790A. Data acquired at 10 Hz. Scale bar = 20 μm.
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Click here for additional data file.
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Movie S2: GSK‐evoked multicellular Ca2+ waves. Pseudo‐coloured active Ca2+ wave fronts (determined by sequential subtraction) showing a GSK‐evoked (20 nM) Ca2+ wave that propagates across four endothelial cells. Cell outlines are overlaid in white. Data acquired at 20 Hz. Scale bar = 20 μm.
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Movie S3: Ca2+ waves stop upon washout of GSK. The grey channel shows basal Ca2+ levels,while the red channel shows Ca2+ activity (red, determined by sequential subtraction). GSK (20 nM) present from start of video and washed out when indicated. Data acquired at 10 Hz. Scale bar = 20 μm.
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Click here for additional data file.
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